EF-2001
PB PROPOSAL
DATA

EFFECT

Anti-Tumour Effect

Anti-Allergy Effect

Intestinal Flora Improvement Effect

Comparison of Immunity-Specific Activity by Bacteria Type

Radioprotective Effect

Immunity-Boosting Effect

Intestinal Pathogen Preventative Effect

Edema Inhibitory Effect

Birth Defect Prevention Effect

Anti-diabetic Effect

Blood Pressure Elevation Inhibition and Improved Liver Function Effects

Cancer Treatment Clinic (1)

- Hyperthermic cancer treatment enhancing effect

- Hyperthermic treatment CT1

- Hyperthermic treatment CT2

- Hyperthermic treatment CT3

Radiotherapy Clinic (2)

- Combined effect with radiotherapy

- Radiotherapy CT1

- Radiotherapy CT2

- Radiotherapy CT3

- Radiotherapy CT4

- Radiotherapy CT5

Overview of Conference Presentations on Immunobiotic Lactic Acid Bacteria EF-2001

Overview of Theses on Immunobiotic Lactic Acid Bacteria EF-2001

COMPANY INFO.
TERM
PUBLICATIONS/VIDEOS

Total IgE, IgG and IgM Measurements of EF-2001


Allergic reaction inhibition and immunity enhancing effect of EF-2001 by measuring total IgE, IgG and IgM

<Result: IgE Measurement>

Antibodies were produced in the EF-2001 group, with a decrease in total IgE concentration compared to the control group. This is thought to be because of an increase in the blood IL-2 level as a result of administering the EF-2001, with cytokine production in the spleen changing from Th2 to Th1.
Accordingly, IgG and IgE decreased, indicating an allergy-inhibitory effect.


<Result: IgG, IgM Measurement>

Antibodies were produced in the EF-2001 group, with an increase in total IgM concentration compared to the control group. However, there was a slight decrease in the total IgG concentration. This is thought to be because the immunostimulatory activity of EF-2001 not only activates macrophages and cell immunity in NK cells and T cells, but also promotes humoral immune response.

   

Copyright© 2008 NIHON BERUMU CO.,LTD ALL Rights Reserved